Dr. Larry R. Kaiser
Known as one of the world's leading experts in thoracic oncology, Dr. Larry R. Kaiser has been treating patients with lung cancer and mesothelioma for more than 30 years. After serving as the chairman and surgeon-in-chief at the University of Pennsylvania Hospital in Philadelphia, Kaiser became the president of the University Texas Health Science Center in Houston as well as a professor of cardiothoracic and vascular surgery for the same institution. In 2011, Kaiser became the CEO of the Temple University Health System and dean of the university's school of medicine. As a board-certified thoracic and cardiac surgeon, Kaiser specializes in treating patients with pleural mesothelioma, lung cancer, and tumors found in the chest. In addition, Kaiser is an acclaimed thoracic surgeon affiliated with more than one dozen professional organizations and a variety of regional cancer centers that offer mesothelioma patients world-class care and access to the best treatment methods available.
Kaiser began his medical training at Tulane University in New Orleans before completing a general surgery residence and advanced fellowship in surgical oncology at UCLA. To finish his training in thoracic and cardiovascular surgery, Kaiser completed two senior residencies at the University of Toronto in Ontario. As a newly qualified surgeon, Kaiser began his professional work at the Sloan-Kettering Cancer Center in New York City before entering the world of medical academia. Since 1988, Kaiser has been a faculty member at the Washington University School of Medicine in St. Louis, the Hospital of the University of Pennsylvania in Philadelphia, the University of Texas in Houston, and Pennsylvania's Temple University.
During his distinguished career, Kaiser has written and co-authored approximately one dozen books and more than 300 medical papers. He is also an editorial board member for the Annals of Surgery, the Annals of Surgical Oncology, and other medical journals related to thoracic and cardiovascular surgery. While working for the University of Pennsylvania, Dr. Kaiser directed the university's research laboratories for thoracic oncology.
Kaiser's most recent mesothelioma research has focused on gene therapy and immunotherapy approaches. He has also invented, patented, and pioneered videoscopic surgical techniques that are ideal for patients with pleural mesothelioma. In addition, Kaiser is a member of the Society of Thoracic Surgeons, the General Thoracic Surgical Club, the American Association of Thoracic Surgery, and other professional groups.
Throughout his 30-year career, Kaiser has developed pioneering surgical techniques and experimented with innovative treatment methods that continue to improve thoracic surgery and mesothelioma care. Kaiser has helped build mesothelioma and thoracic oncology programs across the nation, and he continues to treat mesothelioma patients in Pennsylvania and the surrounding region.